| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Deflin Gayle is a Director at Amphastar Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $221K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Director | Sell | 4,163 | $55.45 | $230,838.35 | -60.5% | |
| May 18, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Director | Sell | 4,519 | $44.01 | $198,888.42 | -52.1% | |
| May 15, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Director | Sell | 1,500 | $43.15 | $64,727.70 | -14.7% |